keyword
https://read.qxmd.com/read/38619184/clinical-prediction-of-opioid-use-disorder-in-chronic-pain-patients-a-cohort-retrospective-study-with-a-pharmacogenetic-approach
#1
JOURNAL ARTICLE
Mónica Escorial, Javier Muriel, Laura Agulló, Thomas Zandonai, César Margarit, Domingo Morales, Ana M Peiró
BACKGROUND: Opioids are widely used in chronic non-cancer pain (CNCP) management. However, they remain controversial due to serious risk of causing opioid use disorder (OUD). Our main aim was to develop a predictive model for future clinical translation that include pharmacogenetic markers. METHODS: An observational study was conducted in 806 pre-screened Spanish CNCP patients, under long-term use of opioids, to compare cases (with OUD, N.=137) with controls (without OUD, N...
April 12, 2024: Minerva Anestesiologica
https://read.qxmd.com/read/38597823/is-there-a-better-way-to-wean-chronic-benzodiazepine-receptor-agonists-use-by-substituting-a-dora-and-starting-cbt-i
#2
JOURNAL ARTICLE
Madeleine Grigg-Damberger
No abstract text is available yet for this article.
February 7, 2024: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://read.qxmd.com/read/38586124/emerging-and-upcoming-therapies-in-insomnia
#3
JOURNAL ARTICLE
Woo-Ju Kim, Ho-Sook Kim
Insomnia, commonly treated with benzodiazepine (BZD) receptor agonists, presents challenges due to associated serious side effects such as abuse and dependence. To address these concerns, many researches have been conducted to develop and advance both pharmacological and non-pharmacological interventions. Dual orexin receptor antagonists (DORAs), which include suvorexant, daridorexant and lemborexant, have recently been approved by United States Food and Drug Administration (US FDA) as a novel pharmacotherapeutic alternative...
March 2024: Translational and clinical pharmacology
https://read.qxmd.com/read/38551874/-pharmacotherapies-for-insomnia
#4
JOURNAL ARTICLE
Marie-Françoise Vecchierini, Damien Léger
PHARMACOTHERAPIES FOR INSOMNIA. The first line of treatment in adult chronic insomnia is cognitive behavioral therapy (CBT). However, its difficult accessibility limited its use and medications are still often prescribed. Considering the drugs with marketing authorization, Z-drugs (zolpidem and zopiclone) if taken at the right hour and dosage promote sleep initiation and have less deleterious effects than benzodiazepines, especially the long-acting ones which should be avoided. This class of drugs cannot be prescribed longer than 28 days...
March 2024: La Revue du Praticien
https://read.qxmd.com/read/38547819/related-factors-of-delirium-after-transsphenoidal-endoscopic-pituitary-adenoma-resection-a-matched-retrospective-cohort-study
#5
JOURNAL ARTICLE
Shusheng Zhang, Yanan Chen, Xiudong Wang, Jun Liu, Yueda Chen, Guobin Zhang
OBJECTIVES: The primary aim of this study is to explore the factors associated with delirium incidence in postoperative patients who have undergone endoscopic transsphenoidal approach surgery for pituitary adenoma. METHODS: The study population included patients admitted to Tianjin Huanhu Hospital's Skull Base Endoscopy Center from January to December 2022, selected through a retrospective cohort study design. The presence of perioperative delirium was evaluated using the 4 'A's Test (4AT) scale, and the final diagnosis of delirium was determined by clinicians...
March 27, 2024: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
https://read.qxmd.com/read/38536419/failure-to-reduce-benzodiazepine-prescriptions-through-the-implementation-of-a-psychological-intervention-for-insomnia-in-an-italian-mental-health-service
#6
JOURNAL ARTICLE
Barbara D'Avanzo, Alberto Parabiaghi, Alessia A Galbussera, Mauro Tettamanti, Igor Monti, Luana Di Gregorio, Francesco Zambello, Marco Maria Goglio, Elisabetta Recla, Wilma Angela Di Napoli, Angelo Barbato
PURPOSE: Despite the evidence of higher effectiveness of psychological interventions for insomnia compared to pharmacological ones, drug prescriptions for insomnia remain frequent. This study has assessed patterns of prescriptions of BZDs for insomnia before and after the delivery of a training in psychological interventions to professionals working in the services of a Department of Mental Health in northern Italy. METHODS: The intervention consisted in two training sessions about psychological interventions for insomnia delivered to professionals of the participating services...
March 27, 2024: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/38519958/sleep-alterations-as-a-function-of-88-health-indicators
#7
JOURNAL ARTICLE
Péter Przemyslaw Ujma, Róbert Bódizs
BACKGROUND: Alterations in sleep have been described in multiple health conditions and as a function of several medication effects. However, evidence generally stems from small univariate studies. Here, we apply a large-sample, data-driven approach to investigate patterns between in sleep macrostructure, quantitative sleep EEG, and health. METHODS: We use data from the MrOS Sleep Study, containing polysomnography and health data from a large sample (N = 3086) of elderly American men to establish associations between sleep macrostructure, the spectral composition of the electroencephalogram, 38 medical disorders, 2 health behaviors, and the use of 48 medications...
March 22, 2024: BMC Medicine
https://read.qxmd.com/read/38514769/long-term-risk-of-psychiatric-disorder-and-psychotropic-prescription-after-sars-cov-2-infection-among-uk-general-population
#8
JOURNAL ARTICLE
Yunhe Wang, Binbin Su, Junqing Xie, Clemente Garcia-Rizo, Daniel Prieto-Alhambra
Despite evidence indicating increased risk of psychiatric issues among COVID-19 survivors, questions persist about long-term mental health outcomes and the protective effect of vaccination. Using UK Biobank data, three cohorts were constructed: SARS-CoV-2 infection (n = 26,101), contemporary control with no evidence of infection (n = 380,337) and historical control predating the pandemic (n = 390,621). Compared with contemporary controls, infected participants had higher subsequent risks of incident mental health at 1 year (hazard ratio (HR): 1...
March 21, 2024: Nature Human Behaviour
https://read.qxmd.com/read/38482541/the-risk-of-delirium-after-sedation-with-propofol-or-midazolam-in-intensive-care-unit-patients
#9
JOURNAL ARTICLE
Thomas G van Gelder, Irene J van Diem-Zaal, Sandra M A Dijkstra-Kersten, Nikki de Mul, Arief Lalmohamed, Arjen J C Slooter
AIM: Knowledge of risk factors may provide strategies to reduce the high burden of delirium in intensive care unit (ICU) patients. We aimed to compare the risk of delirium after deep sedation with propofol versus midazolam in ICU patients. METHODS: In this prospective cohort study, ICU patients who were in an unarousable state for ≥24 h due to continuous sedation with propofol and/or midazolam were included. Patients admitted ≤24 h, those with an acute neurological disorder and those receiving palliative sedation were excluded...
March 14, 2024: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38456246/prescriber-acceptability-of-a-direct-to-patient-intervention-for-benzodiazepine-receptor-agonist-deprescribing-and-behavioural-management-of-insomnia-in-older-adults
#10
JOURNAL ARTICLE
Andrea L Murphy, Justin P Turner, Malgorzata Rajda, Kathleen G Allen, David M Gardner
Behavioural treatments are recommended first-line for insomnia, but long-term benzodiazepine receptor agonist (BZRA) use remains common and engaging patients in a deprescribing consultation is challenging. Few deprescribing interventions directly target patients. Prescribers' support of patient-targeted interventions may facilitate their uptake. Recently assessed in the Your Answers When Needing Sleep in New Brunswick (YAWNS NB) study, Sleepwell (mysleepwell.ca) was developed as a direct-to-patient behaviour change intervention promoting BZRA deprescribing and non-pharmacological insomnia management...
March 8, 2024: Canadian Journal on Aging
https://read.qxmd.com/read/38454372/prevalence-country-specific-prescribing-patterns-and-determinants-of-benzodiazepine-use-in-community-residing-older-adults-in-7-european-countries
#11
JOURNAL ARTICLE
Anna Lukačišinová, Jindra Reissigová, Maja Ortner-Hadžiabdić, Jovana Brkic, Betul Okuyan, Daisy Volmer, Ivana Tadić, Pilar Modamio, Eduardo L Mariño, Konstantine Tachkov, Rosa Liperotti, Graziano Onder, Harriet Finne-Soveri, Hein van Hout, Elizabeth P Howard, Daniela Fialová
BACKGROUND: The use of benzodiazepines (BZDs) in older population is often accompanied by drug-related complications. Inappropriate BZD use significantly alters older adults' clinical and functional status. This study compares the prevalence, prescribing patterns and factors associated with BZD use in community-dwelling older patients in 7 European countries. METHODS: International, cross-sectional study was conducted in community-dwelling older adults (65 +) in the Czech Republic, Serbia, Estonia, Bulgaria, Croatia, Turkey, and Spain between Feb2019 and Mar2020...
March 7, 2024: BMC Geriatrics
https://read.qxmd.com/read/38430553/psychiatric-comorbidities-and-prescribing-tendencies-of-sleep-medications-and-related-medications-in-young-people-with-insomnia-a-united-states-commercial-claims-based-analysis
#12
JOURNAL ARTICLE
Greta Bushnell, Anna Ivanenko, Daniel B Horton, Jessica R Lunsford-Avery, Jonathan Posner, Tobias Gerhard, Elizabeth Suarez, Mark Olfson
STUDY OBJECTIVES: To characterize children and youth newly diagnosed with insomnia and to describe their use of sleep and other related prescription medications. METHODS: Within a commercial claims database (1/1/2016-12/31/2021), we identified children and youth (2-24 years) with a newly recorded insomnia diagnosis (G47.0x;F51.0x) and examined psychiatric diagnoses in the prior 6 months. We evaluated sleep and related prescription medications dispensed in the week after new insomnia diagnoses (i...
March 2, 2024: Sleep
https://read.qxmd.com/read/38421247/implementing-pain-agitation-delirium-and-sleep-deprivation-protocol-in-critically-ill-patients-a-pilot-study-on-pharmacological-interventions
#13
JOURNAL ARTICLE
Punchika Luetrakool, Suthinee Taesotikul, Kanyarat Susantitapong, Chuthamanee Suthisisang, Sunthiti Morakul, Yuda Sutherasan, Viratch Tangsujaritvijit, Pitchaya Dilokpattanamongkol
Critically ill patients frequently experience pain, agitation, delirium, and sleep deprivation, which have been linked to increased mortality and unfavorable clinical outcomes. To address these challenges, the Pain, Agitation, Delirium, and Sleep Deprivation (PADS) protocol was developed, aiming to mitigate mortality and improve clinical outcomes. This study focuses on assessing the protocol's impact using a robust before-and-after study design in the medical and surgical intensive care units (ICUs) at Ramathibodi Hospital...
March 2024: Clinical and Translational Science
https://read.qxmd.com/read/38406216/serotonin-syndrome-an-often-neglected-medical-emergency
#14
REVIEW
Ahmed Badar
Optimum serotonin level in the serotonergic synapses of the central nervous system (CNS) is related to mood, behavior, and sleep. Serotonin syndrome (SS) is a rare yet very dangerous adverse effect resulting from increased serotonin in CNS. The diagnosis of SS is based on the presence of clinical symptoms, which can include agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, tremors, sweating, and diarrhea. SS is invariably caused by inadvertent use of serotonergic medicines...
2024: Journal of Family & Community Medicine
https://read.qxmd.com/read/38401518/exploring-clinical-applications-and-long-term-effectiveness-of-benzodiazepines-an-integrated-perspective-on-mechanisms-imaging-and-personalized-medicine
#15
REVIEW
Yiheng Chang, Xueting Xie, Yudan Liu, Meichen Liu, Huimin Zhang
Benzodiazepines have been long-established treatments for various conditions, including anxiety disorders and insomnia. Recent FDA warnings emphasize the risks of misuse and dependence associated with benzodiazepines. This article highlights their benefits and potential drawbacks from various perspectives. It achieves this by explaining how benzodiazepines work in terms of neuroendocrinology, immunomodulation, sleep, anxiety, cognition, and addiction, ultimately improving their clinical effectiveness. Benzodiazepines play a regulatory role in the HPA axis and impact various systems, including neuropeptide Y and cholecystokinin...
February 23, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38395143/correlates-to-improvement-in-sleep-duration-in-acute-mania-and-depression
#16
JOURNAL ARTICLE
Raphael Golebiowski, Meghna P Mansukhani, Bhanu Prakash Kolla
Objective: To examine sleep duration at admission and discharge and change in sleep duration during hospitalization in patients experiencing a manic episode and compare these parameters to patients hospitalized for major depressive disorder (MDD) during the same time frame. The correlation between sleep duration parameters in those with mania and MDD with length of hospital stay, after accounting for possible confounders, was also examined. Methods: This retrospective study examined patients admitted to an acute care psychiatric unit from 2018 to 2021 with an episode of mania or MDD...
February 20, 2024: Primary Care Companion to CNS Disorders
https://read.qxmd.com/read/38393799/treatment-of-chronic-insomnia-in-adults
#17
JOURNAL ARTICLE
Eric M Matheson, Brandon David Brown, Alexei O DeCastro
Insomnia affects 30% of the U.S. population, with 5% to 15% meeting criteria for chronic insomnia. It can negatively impact quality of life, decrease productivity, increase fatigue and drowsiness, and put patients at higher risk of developing other health problems. Initial treatment focuses on nonpharmacologic therapies such as cognitive behavior therapy, which improves negative thought patterns and behaviors through sleep restriction, stimulus control, and relaxation techniques. Other nonpharmacologic treatments include exercise, mindfulness, and acupuncture...
February 2024: American Family Physician
https://read.qxmd.com/read/38393797/managing-selected-chronic-conditions-in-hospitalized-patients
#18
JOURNAL ARTICLE
Robert L Gauer, Alain Abellada, Matthew Stewart, Ryan Kozloski
The management of chronic illnesses should continue during hospitalization. Some chronic conditions require immediate intervention, whereas intensification of therapy for other conditions may be delayed until after discharge. Factors such as pain, anxiety, poor sleep hygiene, and concurrent illness can result in a transient elevation of blood pressure. Acute lowering of blood pressure in hospitalized patients who do not have target-organ damage is not recommended and may lead to harm. If treatment is needed, intravenous antihypertensive agents should be avoided...
February 2024: American Family Physician
https://read.qxmd.com/read/38380702/alleviating-sleep-disturbances-and-modulating-neuronal-activity-after-ischemia-evidence-for-the-benefits-of-zolpidem-in-stroke-recovery
#19
JOURNAL ARTICLE
Zhi-Gang Zhong, Gui-Jin Tao, Shu-Mei Hao, Hui Ben, Wei-Min Qu, Feng-Yan Sun, Zhi-Li Huang, Mei-Hong Qiu
AIMS: Sleep disorders are prevalent among stroke survivors and impede stroke recovery, yet they are still insufficiently considered in the management of stroke patients, and the mechanisms by which they occur remain unclear. There is evidence that boosting phasic GABA signaling with zolpidem during the repair phase improves stroke recovery by enhancing neural plasticity; however, as a non-benzodiazepine hypnotic, the effects of zolpidem on post-stroke sleep disorders remain unclear. METHOD: Transient ischemic stroke in male rats was induced with a 30-minute middle cerebral artery occlusion...
February 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38351589/new-users-of-anxiolytics-and-sedatives-in-sweden-drug-type-doses-prescribers-characteristics-and-psychiatric-comorbidity-in-more-than-750-000-patients
#20
JOURNAL ARTICLE
Elin Dahlén, Carola Bardage, Paulina Tuvendal, Rickard Ljung
OBJECTIVES: Anxiety and sleep disorders are common in the population and anxiolytics and sedatives are widely used. Our aim was to describe the drug utilization of new users of anxiolytics and sedatives in adults including type of drug, doses, prescribers' characteristics, and psychiatric comorbidity. METHODS: A register-based cohort study of new users (18-64 years) of anxiolytics and sedatives in 2015-2019, free of any such drug 5 years prior to inclusion...
March 2024: International Journal of Methods in Psychiatric Research
keyword
keyword
74589
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.